STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

Contrasting Ketogenic and Mediterranean Diets in Individuals With Type 2 Diabetes and Prediabetes: The Keto-Med Trial

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2
PreDiabetes

Interventions: Behavioral: Mediterranean Diet (Med-Plus)
Behavioral: Well-Formulated Ketogenic Diet (WFKD)

First Posted Date: 2019-01-18

Last Posted Date: 2023-02-21

Lead Sponsor: Stanford University

Target Recruit Count: 61

Registration Number: NCT03810378

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Erector Spinae Plane Versus Interscalene Blocks for Shoulder Surgery

Not Applicable

Completed

Conditions: Anesthesia, Local
Phrenic Nerve Paralysis
Upper Extremity Injury
Shoulder Injury

Interventions: Procedure: Interscalene brachial plexus nerve block
Procedure: Erector spinae plane block

First Posted Date: 2019-01-17

Last Posted Date: 2020-03-05

Lead Sponsor: Stanford University

Target Recruit Count: 30

Registration Number: NCT03807505

Locations: 🇺🇸
Stanford Health Care (SHC), Palo Alto, California, United States

Safety of Iodinated Contrast in Liver Transplant Candidates With Decreased Renal Function Undergoing Coronary CT Angiography

Withdrawn

Conditions: Contrast-induced Nephropathy
Contrast Media
Acute Kidney Injury
Liver Transplantation
Renal Insufficiency, Chronic

Interventions: Diagnostic Test: Intravenous administration of iodinated contrast medium for coronary CT angiography

First Posted Date: 2019-01-16

Last Posted Date: 2022-01-04

Lead Sponsor: Stanford University

Registration Number: NCT03806725

Locations: 🇺🇸
Stanfor University, Stanford, California, United States

Accelerated Intermittent Theta-Burst Stimulation for Opiate Use Disorder

Not Applicable

Withdrawn

Conditions: Opiate Dependence
Depression
Opioid-Related Disorders
Major Depressive Disorder
Opioid-use Disorder
Suicidal Ideation
Opioid Use

Interventions: Device: Accelerated intermittent theta-burst stimulation (aiTBS)

First Posted Date: 2019-01-15

Last Posted Date: 2024-07-16

Lead Sponsor: Stanford University

Registration Number: NCT03804619

Locations: 🇺🇸
Stanford University, Palo Alto, California, United States

Ulipristal Acetate for Cervical Preparation

Early Phase 1

Completed

Conditions: Termination of Pregnancy

Interventions: Drug: Ulipristal Acetate

First Posted Date: 2019-01-14

Last Posted Date: 2020-07-01

Lead Sponsor: Stanford University

Target Recruit Count: 13

Registration Number: NCT03802149

Locations: 🇺🇸
Stanford Health Care, Stanford, California, United States

Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF（Tumor Necrosis Factor）Therapy

Terminated

Conditions: Ulcerative Colitis

Interventions: Drug: Vedolizumab

First Posted Date: 2019-01-14

Last Posted Date: 2020-12-21

Lead Sponsor: Stanford University

Target Recruit Count: 1

Registration Number: NCT03802214

Locations: 🇺🇸
Stanford University, Stanford, California, United States
🇨🇦
University of Western Ontario, London, Ontario, Canada

Brief CBT for Patients Undergoing TAVR

Not Applicable

Completed

Conditions: Depression, Anxiety

Interventions: Behavioral: Brief Bedside CBT

First Posted Date: 2019-01-10

Last Posted Date: 2019-01-10

Lead Sponsor: Stanford University

Target Recruit Count: 146

Registration Number: NCT03798548

Surgical Retinotomy for the Treatment of Glaucoma

Not Applicable

Withdrawn

Conditions: Glaucoma

Interventions: Procedure: Surgical Retinotomy

First Posted Date: 2019-01-09

Last Posted Date: 2024-02-05

Lead Sponsor: Stanford University

Registration Number: NCT03798145

Pain Control Following Sinus Surgery

Phase 4

Completed

Conditions: Opioid Use
Opioid Abuse
Otolaryngologic Disease
Pain
Postoperative Pain
Sinusitis
Narcotic Use

Interventions: Drug: OxyCODONE 5 Mg (milligram) Oral Tablet
Drug: Ibuprofen 600 Mg (milligram) Oral Tablet
Drug: Acetaminophen 650 MG (milligram) Oral Tablet

First Posted Date: 2018-12-21

Last Posted Date: 2021-09-01

Lead Sponsor: Stanford University

Target Recruit Count: 118

Registration Number: NCT03783702

Locations: 🇺🇸
Albert Einstein, Bronx, New York, United States
🇺🇸
Vanderbilt, Nashville, Tennessee, United States
🇺🇸
Stanford Health Care, Stanford, California, United States

and more 3 locations

Characterization of Treatment Responses in Lymphedema

Terminated

Conditions: Lymphedema

Interventions: Drug: Ketoprofen

First Posted Date: 2018-12-21

Last Posted Date: 2023-10-10

Lead Sponsor: Stanford University

Target Recruit Count: 2

Registration Number: NCT03783715

Locations: 🇺🇸
Stanford University, Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy